Overview
Steatocystoma multiplex-natal teeth syndrome is an extremely rare genetic disorder characterized by the combination of steatocystoma multiplex (multiple sebaceous cysts of the skin) and natal teeth (teeth present at birth). Steatocystoma multiplex involves the development of numerous small, smooth, yellowish or skin-colored cystic nodules in the skin, typically located on the trunk, arms, and other areas rich in sebaceous glands. These cysts are filled with an oily or creamy substance derived from sebaceous glands. Natal teeth, which are teeth already erupted at the time of birth, represent the other hallmark feature of this syndrome. The condition primarily affects the skin (integumentary system) and the dental/oral system. This syndrome has been reported in a very limited number of families in the medical literature. The steatocystomas typically become more apparent during adolescence or early adulthood, while the natal teeth are evident at birth. The natal teeth may be loose and may require extraction to prevent aspiration risk in the newborn. Additional features that have been reported in some cases include pachyonychia (thickened nails) and other ectodermal abnormalities. The condition has been linked to mutations in the KRT17 gene, which encodes keratin 17, a protein important in the development of skin appendages, hair follicles, and nails. This places the syndrome within the spectrum of keratin disorders related to pachyonychia congenita. Treatment is primarily symptomatic and supportive. Management of steatocystomas may include surgical excision, incision and drainage, or laser therapy for cosmetically bothersome cysts. Natal teeth are managed by a pediatric dentist, with extraction considered if they are supernumerary or pose a risk of aspiration. There is currently no cure for the underlying genetic condition, and long-term follow-up with dermatology is recommended for ongoing management of skin cysts.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
1 eventAlkeran For Injection: FDA approved
For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableAlkeran For Injection
For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate.
Clinical Trials
View all trials with filters →No actively recruiting trials found for Steatocystoma multiplex-natal teeth syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Steatocystoma multiplex-natal teeth syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Steatocystoma multiplex-natal teeth syndrome.
Community
No community posts yet. Be the first to share your experience with Steatocystoma multiplex-natal teeth syndrome.
Start the conversation →Latest news about Steatocystoma multiplex-natal teeth syndrome
No recent news articles for Steatocystoma multiplex-natal teeth syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Steatocystoma multiplex-natal teeth syndrome
What is Steatocystoma multiplex-natal teeth syndrome?
Steatocystoma multiplex-natal teeth syndrome is an extremely rare genetic disorder characterized by the combination of steatocystoma multiplex (multiple sebaceous cysts of the skin) and natal teeth (teeth present at birth). Steatocystoma multiplex involves the development of numerous small, smooth, yellowish or skin-colored cystic nodules in the skin, typically located on the trunk, arms, and other areas rich in sebaceous glands. These cysts are filled with an oily or creamy substance derived from sebaceous glands. Natal teeth, which are teeth already erupted at the time of birth, represent th
How is Steatocystoma multiplex-natal teeth syndrome inherited?
Steatocystoma multiplex-natal teeth syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Steatocystoma multiplex-natal teeth syndrome typically begin?
Typical onset of Steatocystoma multiplex-natal teeth syndrome is neonatal. Age of onset can vary across affected individuals.
What treatment and support options exist for Steatocystoma multiplex-natal teeth syndrome?
1 patient support program are currently tracked on UniteRare for Steatocystoma multiplex-natal teeth syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.